S&P Futures
3,848.75+39.50(+1.04%)Dow Futures
31,204.00+292.00(+0.94%)Nasdaq Futures
13,087.25+176.25(+1.37%)
DENTSPLY SIRONA Inc. (XRAY)
Chart Events
Performance Outlook
| Previous Close | 52.43 |
| Open | 52.38 |
| Bid | 52.74 x 800 |
| Ask | 54.30 x 900 |
| Day's Range | 52.38 - 53.70 |
| 52 Week Range | 31.58 - 60.47 |
| Volume | 2,661,020 |
| Avg. Volume | 1,329,893 |
| Market Cap | 11.599B |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.36 |
| Earnings Date | Mar 01, 2021 |
| Forward Dividend & Yield | 0.40 (0.76%) |
| Ex-Dividend Date | Mar 25, 2021 |
| 1y Target Est | 58.68 |
Fair Value
Related Research
- Benzinga
Earnings Outlook For Dentsply Sirona
Dentsply Sirona (NASDAQ:XRAY) announces its next round of earnings this Monday, March 01. Here is Benzinga's everything-that-matters guide for this Monday's Q4 earnings announcement. Net Income, Earnings, And Earnings Per Share Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS. Earnings And Revenue Analysts predict Dentsply Sirona will report earnings of $0.64 per share on revenue of $995.70 million. Dentsply Sirona earnings in the same period a year ago was $0.73 per share. Quarterly sales came in at $1.11 billion. Why Analyst Estimates And Earnings Surprises Are Important Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values. View more earnings on XRAY If the company were to match the consensus estimate when it reports Monday, EPS would have fallen 12.33%. Sales would be down 10.46% from the same quarter last year. The company's reported EPS has stacked up against analyst estimates in the past like this: Quarter Q3 2020 Q2 2020 Q1 2020 Q4 2020 EPS Estimate 0.30 -0.02 0.38 0.75 EPS Actual 0.67 -0.18 0.43 0.73 Revenue Estimate 828.87 M 492.55 M 867.83 M 1.09 B Revenue Actual 894.80 M 490.60 M 874.30 M 1.11 B Stock Performance Shares of Dentsply Sirona were trading at $52.43 as of February 25. Over the last 52-week period, shares are up 6.56%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release. Do not be surprised to see the stock move on comments made during its conference call. Dentsply Sirona is scheduled to hold the call at 08:30:00 ET and can be accessed here. See more from BenzingaClick here for options trades from BenzingaA Preview Of StoneCastle Financial's EarningsEx-Dividend Date Insight: Whitestone© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- Zacks
Why Earnings Season Could Be Great for DENTSPLY (XRAY)
DENTSPLY (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- GlobeNewswire
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share. The dividend is payable on April 9, 2021 to holders of record on March 26, 2021. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. Contact Information Investors:Kari DixonVP, Financial Planning & Analysis+1-704-805-1281Kari.Dixon@dentsplysirona.com
